Objective
The aim is to enable the widespread development of innovative payment applications with the active involvement of financial institutions (e.g. banks) providing supporting transaction services by creating an Open Payments Eco-system (OPE). The OPE is the critical step in widening access to payment services and to alternative, open, collaborative, lower cost methods of delivering payment applications to end users (particularly SME’s) who want to make use of payment services within their business. The Eco-system enables the SME developer community to provide creative new payment applications to the market and offers a high degree of re-use of common application components.
OPE has the potential to fundamentally disrupt the current creation and delivery mechanisms for payment services, by providing for the low-cost creation of quality assured payment applications and the building and delivery of payment services, in a controlled and regulatory-compliant environment.
Forecasting reports (Visa Europe – 2011 and PSE Consulting – 2013) indicate a potential market for prepaid payment services in corporate and consumer segments in Europe of >€140bn by 2020. The market application will initially be launched in the UK (2017-18) but quickly rolled out into the rest of Europe (2018 onwards) leveraging the expected OPE common coded regulatory compliance, with Italy, Spain, France and Germany being the focus.
Ixaris specialises in the development of innovative global applications based on open-loop prepaid card schemes and the OPE will add a unique infrastructure to its product portfolio. This will be achieved by opening up the established payment infrastructure and in doing so disrupting the traditional way in which innovation in payments takes place within the current established banking eco-system.
Fields of science
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
W1T 1AN LONDON
United Kingdom
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.